Rhumbline Advisers Dyne Therapeutics, Inc. Transaction History

Rhumbline Advisers

$104 Billion
Q1 2025

A detailed history of Rhumbline Advisers transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 133,627 shares of DYN stock, worth $1.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

133,627

Previous 128,244 4.2%

Holding current value

$1.61 Million

Previous $3.02 Million 49.35%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 08, 2025	BUY	$10.46 - $25.46 $56,306 - $137,051	5,383 Added 4.2%	133,627 $1.53 Million
Q4 2024 Jan 30, 2025	BUY	$23.56 - $35.55 $87,973 - $132,743	3,734 Added 3.0%	128,244 $3.02 Million
Q3 2024 Nov 12, 2024	BUY	$31.94 - $47.04 $93,105 - $137,121	2,915 Added 2.4%	124,510 $4.47 Million
Q2 2024 Aug 01, 2024	BUY	$23.65 - $35.63 $550,240 - $828,967	23,266 Added 23.66%	121,595 $4.29 Million
Q1 2024 May 09, 2024	BUY	$13.06 - $29.18 $288,508 - $644,615	22,091 Added 28.98%	98,329 $2.79 Million
Q4 2023 Feb 08, 2024	BUY	$6.62 - $13.64 $37,515 - $77,297	5,667 Added 8.03%	76,238 $1.01 Million
Q3 2023 Nov 09, 2023	BUY	$8.6 - $12.18 $57,267 - $81,106	6,659 Added 10.42%	70,571 $632,000
Q2 2023 Aug 08, 2023	BUY	$8.53 - $14.28 $108,603 - $181,812	12,732 Added 24.88%	63,912 $719,000
Q1 2023 May 11, 2023	BUY	$10.88 - $15.0 $21,390 - $29,490	1,966 Added 3.99%	51,180 $590,000
Q4 2022 Feb 14, 2023	BUY	$9.37 - $13.8 $3,710 - $5,464	396 Added 0.81%	49,214 $570,000
Q3 2022 Nov 10, 2022	BUY	$7.2 - $15.17 $31,939 - $67,294	4,436 Added 10.0%	48,818 $620,000
Q2 2022 Aug 11, 2022	BUY	$4.36 - $10.5 $30,249 - $72,849	6,938 Added 18.53%	44,382 $305,000
Q1 2022 May 12, 2022	SELL	$6.52 - $12.27 $4,309 - $8,110	-661 Reduced 1.73%	37,444 $361,000
Q4 2021 Feb 10, 2022	SELL	$11.89 - $16.07 $3,388 - $4,579	-285 Reduced 0.74%	38,105 $453,000
Q3 2021 Nov 12, 2021	BUY	$15.6 - $21.46 $21,840 - $30,044	1,400 Added 3.78%	38,390 $623,000
Q2 2021 Aug 05, 2021	BUY	$15.94 - $22.33 $405,545 - $568,119	25,442 Added 220.32%	36,990 $778,000
Q1 2021 May 06, 2021	BUY	$14.0 - $29.3 $161,672 - $338,356	11,548 New	11,548 $179,000

Others Institutions Holding DYN

# of Institutions

217

Shares Held

116M

Call Options Held

322K

Put Options Held

66.2K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $622M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Dyne Therapeutics, Inc. Transaction History